Rasagiline adjunct therapy in patients with Parkinson's disease: Post hoc analyses of the PRESTO and LARGO trials

Rasagiline was an effective first adjunct therapy in levodopa-treated patients; benefited patients with signs of early “wearing off”; improved all cardinal PD symptoms; and further improved symptoms in patients already receiving other adjunctive dopaminergic treatment.